Beta2-adrenoceptor upregulation – IL-17 – COVID-19 It has been reported that nucleotide-binding oligomerization domain 2 (NOD2) can also function as...
Secukinumab – rheumatic-diseases A review by Marije Koenders in Drug Design, Development and Therapy outlines some major features and characteristics...
Glucocorticoid-Resistant IL-17 – Multiple Sclerosis A recent study published in Immunology is perhaps the first to demonstrate a correlation between...
Autism – the Th17–IL-17–IL-17R System A new report published in Science indicates that the key pro-inflammatory cytokine interleukin (IL)-17a may...
Vasoactive Intestinal Peptide Inhibits Th17 Cells A study published by Rebeca Jimeno et al. published in the Journal of Leukocyte...
New subset of T helper cells – multiple sclerosis A study by Wanqiang Sheng and colleagues from the National University...
Neuroendocrine-immunology has achieved substantial progress and growth over the last year. As the BrainImmune mission is to promote the advancement...
Neuropathic Pain – IL-17 A study published in Molecular Medicine Reports provides further evidence that interleukin (IL)-17 contributes to neuropathic...
TLRs-Activated Microglia – Neurotoxic IL-17 A recent PLoS One study indicates that the cross-talk between the brain microglia and T...
Guillain-Barré Syndrome – Th17 A study by Shujuan Li and colleagues from the Jilin University, Changchun, China, suggests that Th17...
Glucocorticoid Resistance – Takayasu Arteritis A study published in the Arthritis & Rheumatology journal is perhaps the first to demonstrate...
IL-17: A Promising Therapeutic Target Since the discovery of T helper 17 (Th17) cells, an increasing body of evidence indicates...